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Abstract Intracerebroventricular (i.c.v.) administration
of L-aspartate (L-Asp) attenuates stress responses in neo-
natal chicks, but the mechanism has not been clarified. In
the present study, three behavioral experiments were car-
ried out under socially isolated stressful conditions exac-
erbated by the use of corticotrophin-releasing factor (CRF).
In Experiment 1, i.c.v. injection of L-Asp attenuated
behavioral stress responses (distress vocalization and active
wakefulness) in a dose-dependent manner. Furthermore,
L-Asp increased time spent standing/sitting motionless with
eyes open and sitting motionless with head dropped
(sleeping posture) in comparison with the group receiving
CRF alone. In Experiment 2, i.c.v. injection of D-Asp dose-
dependently decreased the number of distress vocalizations
and the amount of time spent in active wakefulness. D-Asp
increased the time spent standing/sitting motionless with
eyes open compared with the group receiving CRF alone.
In Experiment 3, we directly compared the effect of L-Asp
with that of D-Asp. Both L- and D-Asp induced sedative
effects under an acutely stressful condition. However,
L-Asp, but not D-Asp, increased the time spent in a sleeping
posture. These results indicate that both L- and D-Asp, when
present in the brain, could induce a sedative effect, while
the mechanism for hypnosis in neonatal chicks may be
different for L-Asp in comparison with D-Asp.
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Introduction
The amino acid L-aspartate (L-Asp) and its enantiomer
D-aspartate (D-Asp) occur in the central nervous system of
various species, including chickens (Neidle and Dunlop
1990), rats (Hashimoto et al. 1995), pigeons (Kera et al.
1996), and humans (Dunlop et al. 1986). L-Asp functions as
a neurotransmitter to stimulate the N-methyl-D-aspartate
(NMDA) receptor (NMDA-R), one of the ionotropic
L-glutamate receptors, even though its binding capacity for
NMDA-R is weaker than that of L-glutamate (Chen et al.
2005). D-Asp, synthesized from L-Asp by aspartate race-
mase, can also directly stimulate the NMDA-R (D’Aniello
et al. 2000; Woloskor et al. 2000). We have previously
demonstrated that under acute social separation stress,
intracerebroventricular (i.c.v.) injection of L-Asp causes a
sedative effect in neonatal chicks (Yamane et al. 2009a).
Furthermore, we have confirmed that L-glutamate and
NMDA have similar effects to those observed with L-Asp
(Yamane et al. 2009b) during acutely stressful conditions.
From these findings, it can be hypothesized that both L-Asp
and D-Asp play an important role in the regulation of
physiological response under acutely stressful conditions
via the NMDA-R.
Behavioral experiments have been carried out using
neonatal chicks undergoing social isolation stress (Felten-
stein et al. 2003; Panksepp et al. 1980; Sahley et al. 1981).
E. Erwan  S. Tomonaga (&)  J. Yoshida  M. Nagasawa 
Y. Ogino  M. Furuse
Laboratory of Regulation in Metabolism and Behavior,
Faculty of Agriculture, Graduate School of Bioresource
and Bioenvironmental Sciences, Kyushu University,
Higashi-ku, Fukuoka 812-8581, Japan
e-mail: shozo@brs.kyushu-u.ac.jp
D. M. Denbow
Department of Animal and Poultry Sciences, Virginia
Polytechnic Institute and State University, Blacksburg,
VA 24061-0306, USA
123
Amino Acids (2012) 43:1969–1976
DOI 10.1007/s00726-012-1272-4
When chicks are isolated, they express characteristic stress-
related behaviors, which include increased distress vocal-
izations (DVs), active wakefulness, and a decrease in
sleeping behavior. Hence, the effect of drugs which have
an anti-anxiety effect can be screened by observing the
behavior of chicks undergoing isolation stress.
Corticotrophin-releasing factor (CRF), a 41-amino acid
peptide hormone produced in the hypothalamus, is a key
regulator of brain excitability associated with stress (Ehlers
et al. 1983). This peptide has multiple biological effects
and plays a central regulatory role in the hypothalamic–
pituitary–adrenal (HPA) axis. It has been shown that the
magnitude of anxiety induced by social separation stress is
increased by CRF (Zhang et al. 2003, 2004; Kurata et al.
2011). CRF administered intracerebroventricularly or
intracerebrally at specific brain sites produces a wide
variety of behavioral effects, all of which are characterized
by increases in arousal or by behavioral manifestations of a
stressful state (Koob et al. 1984; Dunn and Berridge 1990).
Little is known about the central effects of either L- or
D-Asp on the stress response, or about the mechanism by
which these effects occur. In particular, no information is
available on the possible role of isomerization of D-Asp
from L-Asp in terms of the stress response. Therefore, to
test the hypothesis that central L-Asp acts on the stress
responses not only directly but also via its metabolites,
represented by D-Asp, three behavioral experiments were
carried out in the present study: (1) the dose-dependent
effects of L-Asp were examined; (2) the dose-dependent
effects of D-Asp were examined; and (3) a direct compar-
ison was made between L- and D-Asp. To help clarify the
mechanisms by which the central effects occur, in Exper-
iment 3 the effects of L-Asp and D-Asp on levels of brain
monoamines (dopamine [DA], serotonin [5-HT], and their
metabolites) were also investigated because these mono-
amines have been recognized as regulators of behaviors
and/or of stress responses in chicks (Hamasu et al. 2009b;
Saito et al. 2004; Zhang et al. 2003).
Materials and methods
Animals and drugs
One-day-old layer chicks were purchased from a local
hatchery (Murata hatchery, Fukuoka, Japan) and group-
housed in a wire-meshed cage (50 9 35 9 33 cm) in a
group (20–25 birds) at a constant temperature of 30 ± 1 C
and with continuous light until the experimental day.
Chicks were all of the same age and were housed without
an adult. Food (AX, Toyohashi Feed and Mills Co. Ltd.,
Aichi, Japan) and water were available ad libitum. On the
day of the experiment, chicks (6 days old) were assigned to
treatment groups on the basis of their body weight in order
to produce uniform treatment groups. The number of ani-
mals used in each group was kept to the minimum that
would still ensure adequate statistical power. This study
was performed according to the guidance for Animals
Experiments in the Faculty of Agriculture and in the
Graduate Course of Kyushu University and Law No. 105
and Notification No. 6 of the government.
L- and D-Asp were purchased from Wako Pure Chemical
Industries (Osaka, Japan). Rat CRF was purchased from
Peptide Institute, Inc. (Osaka, Japan). The drugs were dis-
solved in a vehicle of 0.85 % saline containing 0.1 % Evans
Blue (Wako Pure Chemical Industries, Ltd., Osaka, Japan).
Procedure for behavioral test
Drugs were injected intracerebroventricularly by microsy-
ringe into the left lateral ventricle of the chicks in a 10-ll
dose, using the method of Davis et al. (1979). Minimal
stress and pain are suffered when this method is used, as
described elsewhere (Koutoku et al. 2005). In Experiment
1, chicks were administered either vehicle CRF (0.01 lg)
or CRF plus L-Asp (0.42, 0.84 or 1.68 lmol). In Experi-
ment 2, chicks were injected with either vehicle CRF
(0.01 lg) or CRF plus D-Asp (0.42, 0.84 or 1.68 lmol).
The doses of L-Asp and D-Asp were based on a previous
report (Yamane et al. 2009a). In Experiment 3, chicks were
injected with either CRF (0.01 lg), CRF plus L-Asp (0.84
or 1.68 lmol) or CRF plus D-Asp (0.84 or 1.68 lmol).
After injection, chicks were immediately placed in a
monitoring cage (40 cm 9 30 cm 9 20 cm acrylic glass)
with paper (changed for each animal) on the floor. Video
cameras were positioned to record on digital versatile disc
(DVD), the behavior of chicks from three different direc-
tions. The postures recorded during a 10-min period were
characterized as (1) active wakefulness, (2) standing/sitting
motionless with eyes open, (3) standing motionless with
eyes closed, and (4) sitting motionless with head drooped
(sleeping posture). The time spent in each posture was
determined by watching the DVDs. In young adult hens,
during both the sleeping posture (head tucked under a
wing) and the resting postures with eyes closed, electro-
physiological sleep was nearly always found to occur (van
Luijtelaar et al. 1987). During the monitoring period,
chicks were deprived of water and food. DVs of the chicks
were simultaneously recorded and counted using Gretchen
software (Excla Inc., Japan). The monitoring systems were
in a separate room to avoid disturbing the animals. At the
conclusion of the experiments, the birds were decapitated
following anesthesia with isoflurane (Mylan Inc., Japan).
The brains were removed and the location of the Evans
Blue dye was confirmed. Data from chicks without dye in
the lateral ventricle were excluded from analysis.
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Analysis of monoamines in the brain
In Experiment 3, the brains were carefully removed and
placed on a cold glass dish. They were divided into two
parts (telencephalon and diencephalon), which were col-
lected and stored at -80 C until analysis. Monoamines
(DA, 5-HT and their metabolites, homovanillic acid [HVA],
3,4-dihydroxyphenylacetic acid [DOPAC], and 5-hydrox-
yindoleacetic acid [5-HIAA]) in these brain regions were
determined as described elsewhere (Tomonaga et al. 2008),
with some modifications. The tissues were weighed and
homogenized in 0.2 M ice-cold perchloric acid solution
containing 0.01 mM EDTA 2Na. Samples were allowed to
sit for 30 min on ice for deproteinization. The homogenate
was centrifuged at 20,000g for 15 min. Supernatants were
adjusted to pH 3 with 1 M sodium acetate and were filtered
through a 0.2-lm filter (Millipore, Bedford, MA, USA). A
30-ll aliquot of filtrate was analyzed using a high-perfor-
mance liquid chromatography system (Eicom, Kyoto,
Japan) with a 150 9 3.0 mm ODS column (SC-5ODS,
Eicom) and an electrochemical detector (ECD-300, Eicom)
at an applied potential of ?750 mV versus an Ag/AgCl
reference analytical electrode. The mobile phase was 0.1 M
sodium phosphate buffer, 2.3 mM sodium 1-octane sul-
fonante, 0.1 mM disodium ethylenediaminetetraacetic acid,
and 17 % methanol, at pH 3.5. The external standard was
used to identify peaks eluting in the chromatogram relating
to retention time and conformation. The detection limits of
the system for all monoamines were 0.1 pg/sample.
Statistical analysis
In Experiments 1 and 2, regression equations were fitted for
data relating to the DVs and the time spent exhibiting
various types of behavior. In all experiments, data were
statistically analyzed by one-way analysis of variance
(ANOVA), and a Tukey–Kramer test was done as a post
hoc test. Significant differences implied p \ 0.05. Values
are presented as mean ± SEM. Statistical analysis was
made using the commercially available package StatView
(Version 5, SAS Institute, Cary, USA, 1998). All data were
first subjected to a Thompson rejection test to eliminate
outliers (p \ 0.01). The remaining data were used.
Results
Experiment 1: Effects of i.c.v. injection of L-Asp
on the behavior of chicks
Figure 1 shows the effects of i.c.v. injection of several
doses of L-Asp with CRF on the number of DVs for 10 min
post injection—a measure of social separation stress. A
significant (p \ 0.05) negative correlation between the
dose of L-Asp and the number of DVs was detected (DVs
[count/10 min] = 408 [SE 86] - 189 [SE 88]X, R2 =
0.181). No significant effect (F[4, 23] = 1.57, p = 0.217)
was found between different treatments in terms of DVs.
Table 1 shows the effect of i.c.v. injection of several doses
of L-Asp with CRF on various behavioral categories of
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Fig. 1 Effects of several doses of L-Asp on DVs in chicks exposed to
social separation stress. Values are means with SEM
Table 1 Effects of i.c.v. injection of several doses of L-Asp and CRF on various behavioral categories of 6-day-old chicks exposed to social
separation stress for 10 min
CRF (lg) 0 0.01 0.01 0.01 0.01
L-Asp (lmol) 0 0 0.42 0.84 1.68
Active wakefulness 398 ± 99ab 479 ± 46a 338 ± 64ab 279 ± 98ab 127 ± 35b
Standing/sitting motionless with eyes open 157 ± 69b 121 ± 46b 257 ± 61ab 259 ± 71ab 401 ± 25a
Standing motionless with eyes closed 6 ± 6 0 ± 0 0 ± 0 24 ± 24 0 ± 0
Sitting motionless with head drooped (sleeping posture) 40 ± 40 0 ± 0 5 ± 5 39 ± 30 73 ± 36
Total 600 600 600 600 600
Values are mean ± SEM in seconds. The number of chicks used in each group was 5–6
Means with different superscripts were significantly different at p \ 0.05
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chicks undergoing social separation stress during the
10-min behavioral observation. There was a significant
effect (F[4, 23] = 3.62, p \ 0.05) between treatments in
terms of the time spent in active wakefulness, and a sig-
nificant negative correlation (p \ 0.001) was observed
between the dose of L-Asp and the time spent in
this posture (active wakefulness [second/10 min] = 455
[SE = 49] - 202 [SE = 50]X, R2 = 0.437). A significant
positive correlation (p \ 0.005) between the dose of L-Asp
and a posture involving standing or sitting motionless with
eyes open was found (standing/sitting motionless with eyes
open [second/10 min] = 144 [SE = 40] ? 154 [SE =
41]X, R2 = 0.404), and a significant effect (F[4, 23] =
3.98, p \ 0.05) was detected among treatments in terms
of this posture. In addition, a significant positive correla-
tion (p \ 0.05) was also detected between the dose
of L-Asp and sitting motionless with head dropped (sleep-
like behavior, sleeping posture [second/10 min] = -4
[SE = 18] ? 46 [SE = 19]X, R2 = 0.222), while no sig-
nificant effect (F[4, 23] = 1.19, p = 0.342) was observed
between treatments. No correlation was found between the
dose of L-Asp and time spent standing motionless with eyes
closed, and no significant effect was observed between
treatments.
Experiment 2: Effects of i.c.v. injection of D-Asp
on the behavior of chicks
Figure 2 shows the effect of i.c.v. injection of several doses
of D-Asp with CRF on the number of DVs during the
10 min of social separation stress. A significant negative
correlation (p \ 0.005) between the dose of D-Asp and the
number of DVs was detected (DVs [count/10 min] = 453
[SE 67] - 270 [SE 72]X, R2 = 0.428), while no significant
effect (F[4, 22] = 2.62, p = 0.063) was found among
treatments in terms of time spent on this behavior. Table 2
shows the effect of i.c.v. injection of several doses of D-Asp
with CRF on various behavioral categories of chicks dur-
ing the 10-min behavioral observation under conditions of
social separation stress. A significant negative correlation
(p \ 0.0001) between the dose of D-Asp and active wake-
fulness was found (active wakefulness [second/10 min] =
522 [SE = 40] - 295 [SE = 43]X, R2 = 0.73), and a sig-
nificant effect (F[4, 20] = 7.35, p \ 0.001) was detected in
this posture among treatments. There was a significant effect
(F[4, 21] = 9.39, p \ 0.0005) in time spent standing or sitting
motionless with eyes open among treatments, and a significant
positive correlation (p \ 0.0001) was observed between the
dose of D-Asp and the time spent in this posture (standing/
sitting motionless with eyes open [second/10 min] = 56
[SE = 40] - 232 [SE = 41]X, R2 = 0.639). There was no
significant effect (F[4, 22] = 0.86, p = 0.506) in time spent
standing motionless with eyes closed. There was no signifi-
cant effect (F[4, 22] = 0.74, p = 0.573) between treatments,
and no correlation was found between the dose of D-Asp and
time spent on sleep-like behavior.
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Fig. 2 Effects of several doses of D-Asp on DVs in chicks exposed to
social separation stress. Values are means with SEM
Table 2 Effects of i.c.v. injection of several doses of D-Asp and CRF on various behavioral categories of 6-day-old chicks exposed to social
separation stress for 10 min
CRF (lg) 0 0.01 0.01 0.01 0.01
D-Asp (lmol) 0 0 0.42 0.84 1.68
Active wakefulness 351 ± 90a 561 ± 20a 329 ± 72a 300 ± 59ab 32 ± 12b
Standing/sitting motionless with eyes open 112 ± 36b 39 ± 20b 178 ± 58b 246 ± 55ab 442 ± 68a
Standing motionless with eyes closed 2 ± 2 0 ± 0 0 ± 0 0 ± 0 0 ± 0
Sitting motionless with head drooped (sleeping posture) 136 ± 76 12 ± 12 93 ± 44 54 ± 50 87 ± 72
Total 600 600 600 600 600
Values are mean ± SEM in seconds. The number of chicks used in each group was 4–6
Means with different superscripts were significantly different at p \ 0.05
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Experiment 3: Comparison of the effects of L-Asp
with those of D-Asp on the behavior of chicks
Figure 3 shows the effect of i.c.v. injection of several doses
of L-Asp or D-Asp with CRF on the number of DVs during
10 min of social separation stress. A significant effect (F[4,
20] = 4.32, p \ 0.05) was detected among treatments. The
number of DVs was reduced with increasing doses of L- or
D-Asp. Table 3 shows the effect of i.c.v. injection of sev-
eral doses of L- or D-Asp with CRF on various behaviors of
chicks during 10 min behavioral observation under condi-
tions of isolation stress. The time spent in active wake-
fulness was significantly reduced (F[4, 20] = 8.38,
p \ 0.001) with i.c.v. injection of L- or D-Asp. Likewise,
i.c.v. injection of either L- or D-Asp significantly increased
(F[4, 21] = 3.36, p \ 0.05) the time spent standing or
sitting motionless with eyes open. L-Asp caused significant
increases (F[4, 18] = 3.81, p \ 0.05) in time spent in
sleep-like behavior. Tables 4 and 5 show the effect of i.c.v.
injection of several doses of L- or D-Asp with CRF on the
monoamine content in the diencephalon and telencephalon.
There were no significant effects on levels of monoamines
in either brain region among treatments, apart from
5-HIAA in the diencephalon (F[5, 24] = 3.31, p \ 0.05).
Discussion
We confirmed that i.c.v. injection of L-Asp can attenuate the
stress response even under acute and highly stressful condi-
tions induced by i.c.v. injected CRF and isolation stress
(Fig. 1; Table 1). These findings are consistent with an earlier
report that i.c.v. injection of L-Asp caused sedative and hyp-
notic effects under conditions of acute social isolation stress
without treatment with CRF (Yamane et al. 2009a). Hamasu
et al. (2009a) revealed that several amino acids, including
Asp, were decreased in the diencephalon of neonatal chicks
exposed to both restraint with isolation and fasting stress. This
fact suggests that central free L-Asp might have an important
role in the stress response. Significant negative correlations
between the dose of L-Asp and a CRF-stimulated stress
response (Fig. 1; Table 1) clearly suggest that L-Asp might
attenuate CRF-induced stress behaviors.
Even though the function of D-Asp during the stress
response in both mammalian and avian brains has not been
well clarified, mounting evidence indicates that this
D-amino acid may act as a putative neuromodulator or
neurotransmitter of the glutamatergic system (Schell et al.
1997; Errico et al. 2008). Here, we investigated whether
i.c.v. injection of D-Asp could attenuate the stress response
induced by CRF and isolation stress. The i.c.v. injection of
D-Asp dose-dependently decreased DVs and time spent in
active wakefulness. On the other hand, D-Asp increased the
time spent standing/sitting motionless with eyes open in
comparison with the group receiving CRF alone. D-Asp
and L-Asp both have a clear function regarding stress
responses.
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Fig. 3 Effects of L- and D-Asp on DVs in chicks exposed to social
separation stress. Values are means with SEM
Table 3 Effects of i.c.v. injection of several doses of L- and D-Asp and CRF on various behavioral categories of 6-day-old chicks exposed to
social separation stress for 10 min
CRF (lg) 0.01 0.01 0.01 0.01 0.01
L-Asp (lmol) 0 0.84 1.68 0 0
D-Asp (lmol) 0 0 0 0.84 1.68
Active wakefulness 406 ± 78a 120 ± 40b 10 ± 3b 122 ± 37b 107 ± 48b
Standing/sitting motionless with eyes open 134 ± 45 322 ± 60 364 ± 42 356 ± 56 356 ± 75
Standing motionless with eyes closed 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0
Sitting motionless with head drooped (sleeping posture) 30 ± 18b 158 ± 77ab 262 ± 26a 122 ± 43ab 46 ± 22b
Total 600 600 600 600 600
Values are mean ± SEM in seconds. The number of chicks used in each group was 4–6
Means with different superscripts were significantly different at p \ 0.05
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In Experiment 3, we confirmed that i.c.v. injection of
L- or D-Asp induced sedation in chicks, while the behavioral
results for the two isomers of Asp vary. L-Asp decreased
the time spent in active wakefulness and increased the time
spent standing/sitting with eyes open and the time spent in
the sleeping posture. On the other hand, D-Asp decreased
the time spent in active wakefulness and increased the time
spent standing/sitting with eyes open, while there was no
significant effect on sleep-like behavior. According to
Hamasu et al. (2010), L-proline and D-proline differentially
induced sedative and hypnotic effects through NMDA and
glycine receptors, respectively. Differences in receptors
between isomers may also be involved in the findings for
Asp. The binding sites of NMDA and a-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) are related to
the brain regions stimulated during the stress response. In
general, the NMDA receptor usually coexists with the
AMPA receptor in the postsynaptic membrane (Nadler
2007). The agonist for both the NMDA-R and the AMPA-
R induced sedative effects in chicks (Yamane et al. 2009b).
L-Asp appears to recognize only NMDA-R, being inactive
at the AMPA receptor and probably also at the kainate
receptor (Dingledine and McBain 1999), and it can act as a
selective NMDA-R agonist in avians (Kubrusly et al.
1998). Hence, it appears likely that the hypnotic and sed-
ative effects of L-Asp may be due to the activation of the
NMDA-R. On the other hand, Molinaro et al. (2010) sug-
gest that D-Asp, but not NMDA, activates the metabotropic
glutamate receptor 5 (mGluR5) coupled to polyphosphoi-
nositide hydrolysis in early postnatal rat brain slices. The
mGluR5 is highly expressed in the early postnatal brain
and is also found in the embryonic brain (Di Giorgi
Gerevini et al. 2004). The mGluR5 could play various roles
in the stress response because stress-induced hyperthermia
was reduced in mGluR5 knockout mice (Brodkin et al.
2002). Therefore, behavioral stress responses may be reg-
ulated by brain D-Asp to stimulate both NMDA-R and
mGluR5, especially in the developmental period. However,
these possibilities should be clarified in further experi-
ments. On the other hand, in rodents, activation of excit-
atory neurotransmission involving the NMDA-R is linked
to the stimulation of the HPA-axis (Zelena et al. 2005).
Therefore, further work should be done to investigate
whether L- and D-Asp in chicks possess same physiological
functions, by focusing on, for example, secretion of corti-
costerone, a major glucocorticoid in avians.
When focusing on monoamine levels in the brain, no
significant changes were observed, except for that involv-
ing 5-HIAA in the diencephalon. Although some experi-
ments suggested that the NMDA-R stimulation is linked to
the regulation of the monoaminergic system in the brain
(Hamasu et al. 2009b; Karlsson et al. 2006; Hanania and
Table 4 Effects of i.c.v. injection of several doses of L- and D-Asp and CRF on monoamine content (pg/mg wet tissue) in the diencephalon of
chicks exposed to social separation stress for 10 min
Intact CRF (0.01 lg) CRF (0.01 lg) ?
L-Asp (0.84 lmol)
CRF (0.01 lg) ?
L-Asp (1.68 lmol)
CRF (0.01 lg) ?
D-Asp (0.84 lmol)
CRF (0.01 lg) ?
D-Asp (1.68 lmol)
DA 1,487 ± 202 1,950 ± 480 1,543 ± 117 2,028 ± 226 1,932 ± 55 1,640 ± 256
DOPAC 42 ± 8 62 ± 12 45 ± 3 58 ± 8 45 ± 3 55 ± 6
HVA 119 ± 16 140 ± 15 105 ± 12 149 ± 30 122 ± 10 111 ± 12
5-HT 497 ± 74 458 ± 60 563 ± 41 443 ± 76 461 ± 36 527 ± 38
5-HIAA 273 ± 10b 395 ± 25a 285 ± 33ab 344 ± 40ab 305 ± 6b 306 ± 14ab
Values are mean ± SEM. The number of chicks used in each group was 4–6
Means with different superscripts were significantly different at p \ 0.05
Table 5 Effects of i.c.v. injection of several doses of L- and D-Asp and CRF on monoamine content (pg/mg wet tissue) in the telencephalon of
6-day-old chicks exposed to social separation stress for 10 min
Intact CRF (0.01 lg) CRF (0.01 lg) ?
L-Asp (0.84 lmol)
CRF (0.01 lg) ?
L-Asp (1.68 lmol)
CRF (0.01 lg) ?
D-Asp (0.84 lmol)
CRF (0.01 lg) ?
D-Asp (1.68 lmol)
DA 545 ± 21 608 ± 26 623 ± 26 574 ± 18 613 ± 44 574 ± 18
DOPAC 28 ± 2 32 ± 1 29 ± 2 31 ± 3 28 ± 1 29 ± 4
HVA 66 ± 6b 76 ± 2ab 69 ± 2ab 83 ± 3a 69 ± 2ab 80 ± 4ab
5-HT 441 ± 13 452 ± 23 499 ± 13 453 ± 5 453 ± 30 457 ± 17
5-HIAA 123 ± 8 141 ± 5 133 ± 7 130 ± 4 140 ± 5 145 ± 10
Values are mean ± SEM. The number of chicks used in each group was 4–6
Means with different superscripts were significantly different at p \ 0.05
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Zahniser 2002), we observed a significant effect only on
5-HIAA in the diencephalon. Thus, it remains unclear
whether there is a relationship between L- or D-Asp and
monoamines, because their levels in the brain do not
always reflect the activity of their neurons. Further study
focusing on monoaminergic systems in the brain is
necessary.
Focusing on injected solutions, the pH decreased to
some extent with L-Asp and with D-Asp (saline 5.93, CRF
5.73, L-Asp [0.42 lmol] ? CRF 3.22, L-Asp [0.84 lmol] ?
CRF 3.14, L-Asp [1.68 lmol] ? CRF 3.16, D-Asp
[0.42 lmol] ? CRF 3.25, D-Asp [0.84 lmol] ? CRF 3.12,
D-Asp [1.68 lmol] ? CRF 3.15). However, the influence
seems minimal when focusing on the difference in effects
between L- and D-Asp, which was the major concern in the
present study. On the other hand, in terms of the inter-
pretation of the dose-dependent behavioral effects of L- or
D-Asp, we cannot deny the possibility that a decrease of pH
might affect the results, even though the dose-dependent
decrease rate of pH seems slight compared with the dose-
dependent behavioral effects of L- and D-Asp. It is possible
that changes in pH themselves influenced the results by
affecting, for example, receptor sensitivity. Further studies
therefore need to be carried out.
In conclusion, central administration of L-Asp attenuated
stress-induced behaviors in neonatal chicks. Furthermore, it
was demonstrated for the first time that D-Asp seems to
have a similar, although not identical, sedative effect.
Further investigation focusing on NMDA-R, mGluR5, and
monoamines may be necessary to gain a better under-
standing of the actions and mechanisms of L- and D-Asp in
the brain.
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